期刊文献+

GABA受体小分子调节剂合成

The Synthesis of Small Molecule Modulators of the GABA Receptor
在线阅读 下载PDF
导出
摘要 γ-氨基丁酸(γ-aminobutyric acid,GABA)是哺乳动物和昆虫中枢神经系统中重要的抑制性神经递质。20世纪70年代末发现GABAA受体是重要医药作用靶标,也是农药杀虫剂的作用靶标。GABAA受体上至少存在4种互相变构体的结合位点,与这些结合位点结合的不同化合物,对氯离子通道的作用机制不同,表现出不同的生物活性。具有杀虫活性的化合物有氟虫腈、林丹、狄氏剂和阿维菌素等,具有医用生物活性的化合物有用于治疗抑郁症的巴比妥、氟硝西泮和氟马西尼以及安定类镇静剂和印防己毒素等抗痉挛剂。分类概述了部分GABA受体小分子调节剂的制备方法与生物活性及其合成路线的研究进展,并对未来开发GABA受体调节剂进行了展望。 Gamma-aminobutyric acid y-aminobutyric acid, GABA) is an important inhibitory neurotransmitter in the central nervous system of mammals and insects. The late 1970s found that the GABAA receptor is an important medicinal target and also the target of pesticides. There are at least four binding sites which are dynamic isomer existing on GABAA receptor. The compounds binding with these sites have different action mechanisms on chloride channel, so show different biological activity. Fipronil, lindane, dieldrin, avermectin and so on are the insecticidal products. Barbiturates, flunitrazepam and flumazenil for controlling depression, antipsychotic tranquilizers and anticonvulsant picrotoxin are medical bioactive compounds.This article reviews the research progress of the preparation, biological activity and the synthetic routes of the part of the GABA receptor small molecule modulators, and looks forward to the future development of GABA receptor modulators.
出处 《世界农药》 CAS 2013年第3期8-13,31,共7页 World Pesticide
基金 国家自然科学基金资助项目(编号:20872093) 国家高技术研究发展计划(863)基金资助项目(编号:2006AA100204) 国家科技支撑基金资助项目(编号:2011BAE06B06) 上海市科委重点基金资助项目(编号:08JC1416800) 上海市教委基金资助项目(编号:08ZZ68 11ZZ122) 上海市重点学科基金资助项目(编号:S30406)
关键词 GABA GABA受体 有机合成 小分子调节剂 GABA GABA receptor organic synthesis small molecule modulators
  • 相关文献

参考文献19

  • 1WINSKY-SOMMERER R. Role of GABAA receptors in the physiology and pharmacology of sleep[J]. European Journal of Neuroscience, 2009 29(9): 1779-1794.
  • 2HIBBS R E, GOUAUX E. Principles of activation and permeation in an anion-selective Cys-loop receptor[J]. Nature, 2011,474(7349): 54-60.
  • 3SEUTIN V, SCUVEE-MOREAU J, DRESSE A. Evidence for a non-GABAergic action of quaternary salts of bicuculline on dopaminergie neurons[J]. Neuropharmacology, 1998, 36(11/12): 1653-1657.
  • 4SEIJAS J A, V,ZQUEZ-TATO M E CARBALLIDO-REBOREDO R. Solvent-free synthesis of functionalized flavones under microwave irradiation[J]. The Journal of Organic Chemistry, 2005, 70(7): 2855-2858.
  • 5LAM P Y S, CLARK C G, LI R, et al. Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor xa inhibitors as novel anticoagulants[J]. Journal of Medicinal Chemistry, 2003, 46(21): 4405-4418.
  • 6STUK T L, ASSINK B K, BATES R C, et al. An efficient and cost-effective synthesis of pagoclone[J]. Organic Process Research & Development, 2003, 7(6): 851-855.
  • 7STERNBACH L H, FRYER R I, KELLER O, et al. Quinazolines and 1,4-benzodiazepines. X. nitro-substituted 5-phenyl-l,4-benzodiazepine derivatives[J]. J. Med. Chem, 1963, 6: 261-265.
  • 8MCDONOUGH J A, DURRWACHTER commercially viable elonazepam process[J] 1997, 1(4): 268-272 J R. Development of a Org. Process Res. Dev,.
  • 9DONOHUE S R, DANNALS R F. A concise and efficient synthesis of flumazenil and its precursor for radiolabeling with fluorine-18[J]. Tetrahedron Letters, 2009, 50(52): 7271-7273.
  • 10YIN W, MAJUMDER S, CLAYTON T, et al. Design, synthesis and subtype selectivity of 3,6-disubstituted beta-earbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse[J]. Bioorg. Meal. Chem, 2010, 18(21): 7548-7564.

二级参考文献6

  • 1TASHMA Z, RAVEH L, LIANI H, et al. Bretazenil, a benzodiazepine receptor partial agonist, as an adjunct in the prophylactic treatment of OP poisoning[ J]. J Appl Toxicol, 2001, 21 ( suppl 1) :115-119.
  • 2NUTT D J. Alcohol ahernativesa goal for psychopharmacology[J]. J Psychopharmacol, 2006, 20(3): 318-320.
  • 3MAGDEN W H, REINACH E K. Diazepine derivatives. US435 3827 ,USA, 4353827[ P]. 1982-10-12.
  • 4KATSIFIS A G, MCPHEE M E, MATFNER F, et al. Synthesis of ^123 I-labelled analogues of imidazobenzodiazepine receptor ligands[J]. Aust J Chem,1999,52( 11 ) :1061-1069.
  • 5TOKUNAGA T, HUME W E, UMEZOME T, et al. Oxindole derivatives as orally active potent growth hormone secretagogues [J]. J Med Chem, 2001, 44(26):4641-4649.
  • 6POLYCHRONOPOULOS P, MAGIATIS P, SKALTSOUNIS A L, et al. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases [ J ]. J Med Chem, 2004,47 (4) :935-946.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部